Saliogen has a total of 18 patents globally, out of which no patents have been granted. Of these 18 patents, more than 77% patents are active. Australia is where Saliogen has filed the maximum number of patents, followed by Canada and New Zealand. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Saliogen.
Saliogen was founded in the year 2020 by Joseph Higgins. This Company is a gene coding company that develops potentially curative therapies for patients with inherited disorders. They Serves customers in the United Sataes of America.
Do read about some of the most popular patents of Saliogen which have been covered by us in this article and also you can find Saliogen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Saliogen patent portfolio.
How many patents does the founder and the CEO of Saliogen have?
The founder Joseph Higgins has 0 patent and CEO Ray Tabibiazar has 5 patents.
How many patents does Saliogen have?
Saliogen has a total of 18 patents globally. These patents belong to 4 unique patent families. Out of 18 patents, 14 patents are active.
How Many Patents did Saliogen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Saliogen Applications Filed | Saliogen Patents Granted |
| 2022 | 5 | – |
| 2021 | 13 | – |
How many Saliogen patents are Alive/Dead?
How Many Patents did Saliogen File in Different Countries?
Countries in which Saliogen Filed Patents
| Country | Patents |
| Australia | 3 |
| Canada | 3 |
| New Zealand | 3 |
| South Africa | 2 |
| Israel | 2 |
| United States Of America | 1 |
Where are Research Centres of Saliogen Patents Located?
The Research Centre for all the Saliogen patents is the United States of America.
List of Saliogen Templates
| Saliogen Patents | Title |
| US20220243227A1 | Transposition-Based Therapies |
| WO2022115579A1 | Mammalian Mobile Element Compositions, Systems And Therapeutic Applications |
| WO2021226141A1 | Transposition-Based Therapies |
| WO2021222654A1 | Compositions And Methods For Treatment Of Inherited Macular Degeneration |
| WO2021222653A1 | Compositions And Methods For Treatment Of Familial Hypercholesterolemia And Elevated Low-Density Lipoprotein Cholesterol |
| AU2021268649A1 | Transposition-Based Therapies |
| AU2021265838A1 | Compositions And Methods For Treatment Of Inherited Macular Degeneration |
| AU2021263938A1 | Compositions And Methods For Treatment Of Familial Hypercholesterolemia And Elevated Low-Density Lipoprotein Cholesterol |
| NZ792666A | Transposition-Based Therapies |
| CA3173889A1 | Transposition-Based Therapies |
| NZ792667A | Compositions And Methods For Treatment Of Inherited Macular Degeneration |
| NZ792662A | Compositions And Methods For Treatment Of Familial Hypercholesterolemia And Elevated Low-Density Lipoprotein Cholesterol |
| CA3175196A1 | Compositions And Methods For Treatment Of Familial Hypercholesterolemia And Elevated Low-Density Lipoprotein Cholesterol |
| CA3175197A1 | Compositions And Methods For Treatment Of Inherited Macular Degeneration |
| IL297718A | Compositions And Methods For Treatment Of Inherited Macular Degeneration |
| IL297756A | Compositions And Methods For Treatment Of Familial Hypercholesterolemia And Elevated Low-Density Lipoprotein Cholesterol |
| ZA202212699A | Compositions And Methods For Treatment Of Familial Hypercholesterolemia And Elevated Low-Density Lipoprotein Cholesterol |
| ZA202212698A | Compositions And Methods For Treatment Of Inherited Macular Degeneration |